What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2025-05-13 compared with 2024-11-13 · 37 added, 54 removed, 5 unchanged (95% of the section changed)

OTHER INFORMATION

10b5-1 Trading Plans

the quarter ended September 30, 2024, the officers and directors listed below adopted , modified , or terminated trading plans intended

to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.

23, 2024 , Scott R.

Henry , a member of our board of directors , entered into a trading plan that provides for the sale of

an aggregate of up to 21,000 shares of our common stock.

The plan will terminate on September 20, 2025 , subject to early

termination for certain specified events set forth in the plan.

24, 2024 , Adam R.

Levy , our Chief Executive Officer and a member of our board of directors, entered into a trading plan that

provides for the sale of an aggregate of up to 32,000 shares of our common stock.

The plan will terminate on September

24, 2025 , subject to early termination for certain specified events set forth in the plan.

“Index to Exhibits” for a description of our exhibits.

of Incorporation of AquaMed Technologies, Inc.

Rule 10b5-1 Trading Plans .

During the three months ended March 31, 2025, no director

or officer of the Company adopted , modified or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading

arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

See “Index to Exhibits” for a description

of our exhibits.

Index to Exhibits

Certificate of Incorporation of AquaMed Technologies, Inc.

(incorporated by reference to Exhibit 3.1 to Form S-1, filed with the SEC on January 9, 2019).

of Amendment to Certificate of Incorporation of AquaMed Technologies, Inc.

(incorporated by reference to Exhibit 3.2 to Form S-1,

filed with the SEC on January 9, 2019).

and Restated Certificate of Incorporation of AquaMed Technologies, Inc.

Certificate of Amendment to Certificate of Incorporation of AquaMed Technologies, Inc.

(incorporated by reference to Exhibit 3.2 to Form S-1, filed with the SEC on January 9, 2019).

Amended and Restated Certificate of Incorporation of AquaMed Technologies, Inc.

(incorporated by reference to Exhibit 3.3 to Amendment No.

1 to Form S-1, filed with the SEC on March 11, 2019).

of Amendment to the Amended and Restated Certificate of Incorporation of AquaMed Technologies, Inc.

(incorporated by reference to

Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on November 14, 2019)

of Amendment to the Amended and Restated Certificate of Incorporation of NexGel, Inc.

(incorporated by reference to Exhibit 3.1 to

the Current Report on Form 8-K, filed with the SEC on May 29, 2020)

of Amendment to the Amended and Restated Certificate of Incorporation of NexGel, Inc.

(incorporated by reference to Exhibit 3.1 to

the Current Report on Form 8-K, filed with the SEC on August 2, 2021)

and Restated Bylaws of AquaMed Technologies, Inc.

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of AquaMed Technologies, Inc.

(incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on November 14, 2019)

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of NexGel, Inc.

(incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on May 29, 2020)

Certificate of Amendment to the Amended and Restated Certificate of Incorporation of NexGel, Inc.

(incorporated by reference to Exhibit 3.1 to the Current Report on Form 8-K, filed with the SEC on August 2, 2021)

Amended and Restated Bylaws of AquaMed Technologies, Inc.

(incorporated by reference to Exhibit 3.5 to Amendment No.

1 to Form S-1, filed

with the SEC on March 11, 2019).

Certification

of Chief Executive Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.

Certification

of Chief Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.

Certification

of Chief Executive Officer Pursuant to Section 18 U.S.C.

Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act

Certification

of Chief Financial Officer Pursuant to Section 18 U.S.C.

Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act

following materials from the Company’s Quarterly Report on Form 10-Q for the fiscal quarter September 30, 2024, formatted in

iXBRL (Inline eXtensible Business Reporting Language), (i) Balance Sheets, (ii) Statements of Operations, (iii) Statements of Stockholders’

Equity, (iv) Statements of Cash Flows, and (v) Notes to the Financial Statements.

Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit).

exhibits and schedules have been omitted and the Company agrees to furnish supplementary to the Securities and Exchange Commission

a copy of any omitted exhibits upon request.

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned thereunto duly authorized.

November 13, 2024

Executive Officer

Executive Officer)

Financial Officer

Financial Officer)

1 to Form S-1, filed with the SEC on March 11, 2019).

Certification of Chief Executive Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.

Certification of Chief Financial Officer Pursuant to Section 302 of Sarbanes-Oxley Act of 2002.

Certification of Chief Executive Officer Pursuant to Section 18 U.S.C.

Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Certification of Chief Financial Officer Pursuant to Section 18 U.S.C.

Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

The following materials from the Company’s Quarterly Report on Form 10-Q for the fiscal quarter March 31, 2025, formatted in iXBRL (Inline eXtensible Business Reporting Language), (i) Balance Sheets, (ii) Statements of Operations, (iii) Statements of Stockholders’ Equity, (iv) Statements of Cash Flows, and (v) Notes to the Financial Statements.

Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit).

Filed herewith.

Certain exhibits and schedules have been omitted and the Company agrees to furnish supplementary to the Securities and Exchange Commission a copy of any omitted exhibits upon request.

Pursuant to the requirements of the Securities Exchange

Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

/s/ Adam Levy

Chief Executive Officer

(Principal Executive Officer)

/s/ Joseph F.

Chief Financial Officer

(Principal Financial Officer)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q

Item 5. Other Information